Amisulpride Global Patent Coverage & Expiry Overview

Track protection status across key markets to assess launch feasibility.

Start your free 7-Day Trial! Book a demo to explore our global patent data.

It is formulated by 1 pharmaceutical company such as ACACIA. It is marketed under 1 brand name, including BARHEMSYS. Available in 2 different strengths, such as 5MG/2ML (2.5MG/ML), 10MG/4ML (2.5MG/ML), and administered through 1 route including SOLUTION;INTRAVENOUS.

Strategic Dashboard

info

insightsStrategic Insights

Sourcing & Feasibility

check_circle API availability: autorenew Loading API feasibility...

groups Licensing: 1 potential partners

calendar_todayUS Launch window: autorenew Loading launch window...

timeline Key Patent Barrier & Expiry Timeline

autorenew Loading patent barriers...

factoryGeneric Manufacturer Snapshot

autorenew Loading manufacturers...

gavelRisk & Opportunity Summary

dangerous Risk: autorenew Loading risk analysis...

watch_later Watch: autorenew Loading watch analysis...

rocket_launch Opportunity: autorenew Loading opportunity analysis...

Country

flag

Legal Status

gavel

Expiry From

calendar_today

Expiry To

calendar_today

Access Global Patent Data

Stay ahead with worldwide patent expiry and latest updates.

✓ Comprehensive global patent expiry timelines

✓ Full patent family details and status updates

Unlock Global Patents

Orange Book Drug Approval Timeline

FDA approval history for this ingredient

NDA (New Drug Application) ANDA (Generic Application)

Access Global Exclusivity and Patent Expiry Extensions

Stay ahead with worldwide patent expiry insights, exclusivity data, and latest updates.

✓ Comprehensive global patent expiry timelines

✓ Full patent family details and status updates

✓ Latest exclusivity data and extensions

Unlock Global Access

US Orange Book Patents Expiration Timeline

Key expiration dates for US patents covering this ingredient

View Global Patents Expiration Timeline

Stay ahead with worldwide patent expiry insights, market data, and research updates.

✓ Comprehensive global patent expiry timelines

✓ Full patent family details and status updates

Unlock Global Patent Timeline

Orange Book Drug Strengths

Latest drug strengths approved by FDA

Strength	Route of Administration	Companies	Latest Approval Date

Orange Book Patents

Patents approved by the FDA for the ingredient

	Patent Number	Publication Date	Legal Status	Patent Expiry Date
{"application_id":"73163","ingredient":"AMISULPRIDE","trade_name":"BARHEMSYS","family_id":"287e9808e92b4f8c9c1a","publication_number":"US10525033B2","cleaned_patent_number":"10525033","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2031-03-10","publication_date":"2020-01-07","legal_status":"Granted"}	US10525033B2 Formulation	07 Jan, 2020	Granted	10 Mar, 2031
{"application_id":"139385","ingredient":"AMISULPRIDE","trade_name":"BARHEMSYS","family_id":"","publication_number":"US12194022B2","cleaned_patent_number":"12194022","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2031-03-10","publication_date":"2025-01-14","legal_status":"Granted"}	US12194022B2	14 Jan, 2025	Granted	10 Mar, 2031
{"application_id":"73110","ingredient":"AMISULPRIDE","trade_name":"BARHEMSYS","family_id":"287e9808e92b4f8c9c1a","publication_number":"US9545426B2","cleaned_patent_number":"9545426","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2031-03-10","publication_date":"2017-01-17","legal_status":"Granted"}	US9545426B2	17 Jan, 2017	Granted	10 Mar, 2031
{"application_id":"73161","ingredient":"AMISULPRIDE","trade_name":"BARHEMSYS","family_id":"287e9808e92b4f8c9c1a","publication_number":"US9889118B2","cleaned_patent_number":"9889118","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2031-03-10","publication_date":"2018-02-13","legal_status":"Granted"}	US9889118B2	13 Feb, 2018	Granted	10 Mar, 2031
{"application_id":"73159","ingredient":"AMISULPRIDE","trade_name":"BARHEMSYS","family_id":"287e9808e92b4f8c9c1a","publication_number":"US9084765B2","cleaned_patent_number":"9084765","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-02-26","publication_date":"2015-07-21","legal_status":"Granted"}	US9084765B2	21 Jul, 2015	Granted	26 Feb, 2034
{"application_id":"242126","ingredient":"AMISULPRIDE","trade_name":"BARHEMSYS","family_id":"","publication_number":"US12329740B2","cleaned_patent_number":"12329740","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2038-02-09","publication_date":"2025-06-17","legal_status":"Granted"}	US12329740B2	17 Jun, 2025	Granted	09 Feb, 2038
{"application_id":"73167","ingredient":"AMISULPRIDE","trade_name":"BARHEMSYS","family_id":"78ed782915944373ad82","publication_number":"US11357753B2","cleaned_patent_number":"11357753","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2038-02-09","publication_date":"2022-06-14","legal_status":"Granted"}	US11357753B2	14 Jun, 2022	Granted	09 Feb, 2038
{"application_id":"139384","ingredient":"AMISULPRIDE","trade_name":"BARHEMSYS","family_id":"","publication_number":"US12005042B2","cleaned_patent_number":"12005042","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2038-02-09","publication_date":"2024-06-11","legal_status":"Granted"}	US12005042B2	11 Jun, 2024	Granted	09 Feb, 2038

Recent Clinical Trials

Latest clinical trials and research studies for this ingredient

NCT ID	Title	Status	Phase	Conditions	Start Date	Completion Date

API Suppliers/Manufacturer (Branded/Generic companies)

Manufacturing Locations

Filter by Country

View Complete Supplier List

Unlock access to all suppliers of Amisulpride

✓ Access a comprehensive list of global suppliers

✓ Get information on each supplier

Unlock Suppliers

Note: Patent expirations and exclusivity timelines are dynamic and may shift based on litigation, regulatory extensions, and maintenance filings. Regular monitoring is advised.